Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

Lilly says its experimental drug retatrutide met the primary endpoint and key secondary endpoints in a new study.

Retatrutide is an investigational once-weekly triple hormone (glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon) receptor agonist.

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals ...

When it comes to fat loss, one thing is for certain: what you eat matters. However, many people wrongly believe that some ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase 2 clinical trial. If approved, the drug, called MariTide, could make Amgen ...

Weight loss injections are prescription medications to help with weight loss. They can help alter a person’s appetite and metabolism, curbing hunger and reducing calorie intake. Weight loss injections ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with overweight and type 1 diabetes using ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Our hunger can howl at all times of day or night. That's why intermittent fasting leaves some of us wanting more. If you've ...